Atrial Flutter: up‐to‐date Problem Evaluation with Clinical Positions
https://doi.org/10.18087/cardio.2020.1.n693
Abstract
The review provides current ideas about the etiology and prevalence of atrial flutter (AF), mechanism and substrate of arrhythmogenesis, and principles of clinical and electrophysiological classification of this arrhythmia. Methods for conservative and surgical treatments of AF, including their comparative aspect, are described in detail. The review presented recent data on efficacy and potential risks of different approaches to reversing the arrhythmia. The authors indicated a need for early diagnosis and strict control of the sinus rhythm in AF, which would help a successful intervention not only to completely cure the existing arrhythmia but also to prevent other heart rhythm disorders, primarily atrial fibrillation.
About the Authors
K. V. Potapova
Privolzhsky Research Medical University
Russian Federation
Nizhniy Novgorod
Russian Federation
Nizhniy Novgorod
V. P. Nosov
Privolzhsky Research Medical University
Russian Federation
Nizhniy Novgorod
Russian Federation
Nizhniy Novgorod
L. Y. Koroleva
Privolzhsky Research Medical University
Russian Federation
Nizhniy Novgorod
Russian Federation
Nizhniy Novgorod
N. V. Amineva
Privolzhsky Research Medical University
Russian Federation
Nizhniy Novgorod
Russian Federation
Nizhniy Novgorod
References
1. Tai C-T, Huang J-L, Lee P-C, Ding Y-A, Chang M-S, Chen S-A. High-Resolution Mapping Around the Crista Terminalis During Typical Atrial Flutter:. New Insights into Mechanisms. Journal of Cardiovascular Electrophysiology. 2004;15(4):406–14. DOI: 10.1046/j.1540-8167.2004.03535.x
2. Cemin R, Manfrin M, Daves M, Rauhe W, Maggioni AP. Ten years differences in recently onset atrial fibrillation and flutter incidence and management. Monaldi Archives for Chest Disease. 2015;82(3):153–9. DOI: 10.4081/monaldi.2014.56
3. Feld GK, Fleck RP, Chen PS, Boyce K, Bahnson TD, Stein JB et al. Radiofrequency catheter ablation for the treatment of human type 1 atrial flutter. Identification of a critical zone in the reentrant circuit by endocardial mapping techniques. Circulation. 1992;86(4):1233–40. DOI: 10.1161/01.CIR.86.4.1233
4. Cardiac electrophysiology: from cell to bedside. Zipes DP, Jalife J, Stevenson WG, editors -Philadelphia, PA: Elsevier;2018. -1389 p. ISBN 978-0-323-44733-1
5. Cosio FG, López-Gil M, Goicolea A, Arribas F, Barroso JoséL. Radiofrequency ablation of the inferior vena cava-tricuspid valve isthmus in common atrial flutter. The American Journal of Cardiology. 1993;71(8):705–9. DOI: 10.1016/0002-9149(93)91014-9
6. Rahman F, Wang N, Yin X, Ellinor PT, Lubitz SA, LeLorier PA et al. Atrial flutter: Clinical risk factors and adverse outcomes in the Framingham Heart Study. Heart Rhythm. 2016;13(1):233–40. DOI: 10.1016/j.hrthm.2015.07.031
7. Lesh MD, Van Hare GF, Epstein LM, Fitzpatrick AP, Scheinman MM, Lee RJ et al. Radiofrequency catheter ablation of atrial arrhythmias. Results and mechanisms. Circulation. 1994;89(3):1074–89. DOI: 10.1161/01.CIR.89.3.1074
8. Braunwald’s heart disease: a textbook of cardiovascular medicine. Zipes DP, Libby P, Bonow RO, Mann DL, Tomaselli GF, Braunwald E, editors -Philadelphia, PA: Elsevier;2019. -1944 p. ISBN 978-0-323-55592-0
9. ai C-T, Chen S-A, Chiang C-E, Lee S-H, Ueng K-C, Wen Z-C et al. Electrophysiologic Characteristics and Radiofrequency Catheter Ablation in Patients with Clockwise Atrial Flutter. Journal of Cardiovascular Electrophysiology. 1997;8(1):24–34. DOI: 10.1111/j.1540-8167.1997.tb00605.x
10. Ardashev A.V. Atrial flutter: clinical electrophysiology and catheter ablation. -M.: Medpraktika-M;2012. -229 p. [Russian] ISBN 978-5-98803-284-7
11. Cosio FG, Goicolea A, López-Gil M, Arribas F, Barroso J, Chicote R. Atrial endocardial mapping in the rare form of atrial flutter. The American Journal of Cardiology. 1990;66(7):715–20. DOI: 10.1016/0002-9149(90)91136-T
12. Manolis AS. Contemporary Diagnosis and Management of Atrial Flutter: A Continuum of Atrial Fibrillation and Vice Versa? Cardiology in Review. 2017;25(6):289–97. DOI: 10.1097/CRD.0000000000000162
13. Olshansky B, Okumura K, Hess PG, Waldo AL. Demonstration of an area of slow conduction in atrial flutter. Journal of the American College of Cardiology. 1990;16(7):1639–48. DOI: 10.1016/0735-1097(90)90314-F
14. Kushakovsky M.S., Grishkin Yu.N. Heart arrhythmias. Heart rhythm and conduction disorders. Causes, mechanisms, electrocardiographic and electrophysiological diagnosis, clinic, treatment: A guide for doctors. -4th ed. -St. Petersburg: Foliant;2014. -718 p. [Russian] ISBN 978-5-93929-245-0
15. Feld GK, Mollerus M, Birgersdotter-Green U, Fujimura O, Bahnson TD, Boyce K et al. Conduction Velocity in the Tricuspid ValveInferior Vena Cava Isthmus is Slower in Patients With Type I Atrial Flutter Compared to Those Without a History of Atrial Flutter. Journal of Cardiovascular Electrophysiology. 1997;8(12):1338–48. DOI: 10.1111/j.1540-8167.1997.tb01030.x
16. Josephson ME, Josephson ME. Josephson’s clinical cardiac electrophysiology: techniques and interpretations. -Boston: Wolters Kluwer;2016. -890 p. ISBN 978-1-4511-8741-0
17. Spach MS, Dolber PC, Heidlage JF. Influence of the passive anisotropic properties on directional differences in propagation following modification of the sodium conductance in human atrial muscle. A model of reentry based on anisotropic discontinuous propagation. Circulation Research. 1988;62(4):811–32. DOI: 10.1161/01.RES.62.4.811
18. Aguilar M, Nattel S. The pioneering work of George Mines on cardiac arrhythmias: groundbreaking ideas that remain influential in contemporary cardiac electrophysiology. The Journal of Physiology. 2016;594(9):2377–86. DOI: 10.1113/JP270506
19. Cabrera JA, Sánchez-Quintana D, Farré J, Rubio JM, Ho SY. The Inferior Right Atrial Isthmus: Further Architectural Insights for Current and Coming Ablation Technologies. Journal of Cardiovascular Electrophysiology. 2005;16(4):402–8. DOI: 10.1046/j.1540-8167.2005.40709.x
20. Patel NJ, Deshmukh A, Pau D, Goyal V, Patel SV, Patel N et al. Contemporary utilization and safety outcomes of catheter ablation of atrial flutter in the United States: Analysis of 89,638 procedures. Heart Rhythm. 2016;13(6):1317–25. DOI: 10.1016/j.hrthm.2016.02.005
21. Chaplygina E.V., Chudinov G.V., Kornienko N.A. Structural peculiarities in electroanatomi right atrium mapping. Journal of Fundamental Medicine and Biology. 2012;2:50–4. [Russian]
22. Levin A.M., Vysokovich V.K. The basis for clinical diagnosis: For physicians and students. 2nd ed. -Petrograd: New in medicine;1916. -809 p. [Russian]
23. Saoudi N, Cosio F, Waldo A, Chen SA, Iesaka Y, Lesh M et al. A classification of atrial flutter and regular atrial tachycardia according to electrophysiological mechanisms and anatomical bases. A Statement from a Joint Expert Group from the Working Group of Arrhythmias of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. European Heart Journal. 2001;22(14):1162–82. DOI: 10.1053/euhj.2001.2658
24. Lang G.F. Classification and nomenclature of diseases of the cardiovascular system. Therapeutic Archive. 1934;12(1):1–29. [Russian]
25. Huang SK, Miller JM. Catheter ablation of cardiac arrhythmias. 4th ed. Elsevier;2019. 834 p. ISBN 978-0-323-52992-1
26. Olgin JE, Kalman JM, Lesh MD. Conduction Barriers in Human Atrial Flutter: Correlation of Electrophysiology and Anatomy. Journal of Cardiovascular Electrophysiology. 1996;7(11):1112–26. DOI: 10.1111/j.1540-8167.1996.tb00488.x
27. Huang JL, Tai C-T, Lin Y-J, Huang B-H, Lee K-T, Higa S et al. Substrate Mapping to Detect Abnormal Atrial Endocardium With Slow Conduction in Patients With Atypical Right Atrial Flutter. Journal of the American College of Cardiology. 2006;48(3):492–8. DOI: 10.1016/j.jacc.2006.03.045
28. Tai C-T, Huang J-L, Lee P-C, Ding Y-A, Chang M-S, Chen S-A. High-Resolution Mapping Around the Crista Terminalis During Typical Atrial Flutter:. New Insights into Mechanisms. Journal of Cardiovascular Electrophysiology. 2004;15(4):406–14. DOI: 10.1046/j.1540-8167.2004.03535.x
29. Giehm-Reese M, Lukac P, Kristiansen SB, Jensen HK, Gerdes C, Kristensen J et al. Outcome after catheter ablation for left atrial flutter. Scandinavian Cardiovascular Journal. 2019;53(3):133–40. DOI: 10.1080/14017431.2019.1612086
30. Feld GK, Fleck RP, Chen PS, Boyce K, Bahnson TD, Stein JB et al. Radiofrequency catheter ablation for the treatment of human type 1 atrial flutter. Identification of a critical zone in the reentrant circuit by endocardial mapping techniques. Circulation. 1992;86(4):1233–40. DOI: 10.1161/01.CIR.86.4.1233
31. Zhou G, Hu J, Guo X, Liu X, Yang J, Sun Q et al. Very long-term outcome of catheter ablation of post-incisional atrial tachycardia: Role of incisional and non-incisional scar. International Journal of Cardiology. 2016;205:72–80. DOI: 10.1016/j.ijcard.2015.12.004
32. Cosio FG, López-Gil M, Goicolea A, Arribas F, Barroso JoséL. Radiofrequency ablation of the inferior vena cava-tricuspid valve isthmus in common atrial flutter. The American Journal of Cardiology. 1993;71(8):705–9. DOI: 10.1016/0002-9149(93)91014-9
33. Pérez FJ, Wood MA, Schubert CM. Effects of Gap Geometry on Conduction Through Discontinuous Radiofrequency Lesions. Circulation. 2006;113(14):1723–9. DOI: 10.1161/CIRCULATIONAHA.105.596593
34. Lesh MD, Van Hare GF, Epstein LM, Fitzpatrick AP, Scheinman MM, Lee RJ et al. Radiofrequency catheter ablation of atrial arrhythmias. Results and mechanisms. Circulation. 1994;89(3):1074–89. DOI: 10.1161/01.CIR.89.3.1074
35. January CT, Wann LS, Calkins H, Chen LY, Cigarroa JE, Cleveland JC et al. 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation. Heart Rhythm. 2019;16(8):e66–93. DOI: 10.1016/j.hrthm.2019.01.024
36. ai C-T, Chen S-A, Chiang C-E, Lee S-H, Ueng K-C, Wen Z-C et al. Electrophysiologic Characteristics and Radiofrequency Catheter Ablation in Patients with Clockwise Atrial Flutter. Journal of Cardiovascular Electrophysiology. 1997;8(1):24–34. DOI: 10.1111/j.1540-8167.1997.tb00605.x
37. Vadmann H, Nielsen PB, Hjortshøj SP, Riahi S, Rasmussen LH, Lip GYH et al. Atrial flutter and thromboembolic risk: a systematic review. Heart. 2015;101(18):1446–55. DOI: 10.1136/heartjnl-2015-307550
38. Cosio FG, Goicolea A, López-Gil M, Arribas F, Barroso J, Chicote R. Atrial endocardial mapping in the rare form of atrial flutter. The American Journal of Cardiology. 1990;66(7):715–20. DOI: 10.1016/0002-9149(90)91136-T
39. Gula LJ, Redfearn DP, Jenkyn KB, Allen B, Skanes AC, Leong-Sit P et al. Elevated Incidence of Atrial Fibrillation and Stroke in Patients With Atrial Flutter—A Population-Based Study. Canadian Journal of Cardiology. 2018;34(6):774–83. DOI: 10.1016/j.cjca.2018.01.001
40. Olshansky B, Okumura K, Hess PG, Waldo AL. Demonstration of an area of slow conduction in atrial flutter. Journal of the American College of Cardiology. 1990;16(7):1639–48. DOI: 10.1016/0735-1097(90)90314-F
41. Al-Kawaz M, Omran SS, Parikh NS, Elkind MSV, Soliman EZ, Kamel H. Comparative Risks of Ischemic Stroke in Atrial Flutter versus Atrial Fibrillation. Journal of Stroke and Cerebrovascular Diseases. 2018;27(4):839–44. DOI: 10.1016/j.jstrokecerebrovasdis.2017.10.025
42. Feld GK, Mollerus M, Birgersdotter-Green U, Fujimura O, Bahnson TD, Boyce K et al. Conduction Velocity in the Tricuspid ValveInferior Vena Cava Isthmus is Slower in Patients With Type I Atrial Flutter Compared to Those Without a History of Atrial Flutter. Journal of Cardiovascular Electrophysiology. 1997;8(12):1338–48. DOI: 10.1111/j.1540-8167.1997.tb01030.x
43. Flaker G, Lopes RD, Al-Khatib SM, Hermosillo AG, Hohnloser SH, Tinga B et al. Efficacy and Safety of Apixaban in Patients After Cardioversion for Atrial Fibrillation. Journal of the American College of Cardiology. 2014;63(11):1082–7. DOI: 10.1016/j.jacc.2013.09.062
44. Spach MS, Dolber PC, Heidlage JF. Influence of the passive anisotropic properties on directional differences in propagation following modification of the sodium conductance in human atrial muscle. A model of reentry based on anisotropic discontinuous propagation. Circulation Research. 1988;62(4):811–32. DOI: 10.1161/01.RES.62.4.811
45. Monteiro JMC, San-Martin DL, Silva BCG, Souza IFB, Oliveira Filho J, Jesus P. Dabigatran and warfarin in nonvalvular atrial fibrillation or atrial flutter in outpatient clinic practice in Brazil. Arquivos de NeuroPsiquiatria. 2019;77(2):80–3. DOI: 10.1590/0004-282x20190005
46. Cabrera JA, Sánchez-Quintana D, Farré J, Rubio JM, Ho SY. The Inferior Right Atrial Isthmus: Further Architectural Insights for Current and Coming Ablation Technologies. Journal of Cardiovascular Electrophysiology. 2005;16(4):402–8. DOI: 10.1046/j.1540-8167.2005.40709.x
47. Lehrmann H, Weber R, Park C, Allgeier J, Schiebeling-Römer J, Arentz T et al. “Dormant transisthmus conduction” revealed by adenosine after cavotricuspid isthmus ablation. Heart Rhythm. 2012;9(12):1942–6. DOI: 10.1016/j.hrthm.2012.08.020
48. Chaplygina E.V., Chudinov G.V., Kornienko N.A. Structural peculiarities in electroanatomi right atrium mapping. Journal of Fundamental Medicine and Biology. 2012;2:50–4. [Russian]
49. Brugada J, Katritsis DG, Arbelo E, Arribas F, Bax JJ, Blomström-Lundqvist C et al. 2019 ESC Guidelines for the management of patients with supraventricular tachycardiaThe Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC). European Heart Journal. 2019;ehz467. [Epub ahead of print]. DOI: 10.1093/eurheartj/ehz467
50. Saoudi N, Cosio F, Waldo A, Chen SA, Iesaka Y, Lesh M et al. A classification of atrial flutter and regular atrial tachycardia according to electrophysiological mechanisms and anatomical bases. A Statement from a Joint Expert Group from the Working Group of Arrhythmias of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. European Heart Journal. 2001;22(14):1162–82. DOI: 10.1053/euhj.2001.2658
51. Jin M-N, Song C, Kim T-H, Uhm J-S, Pak H-N, Lee M-H et al. CHA2DS2-VASc Score in the Prediction of Ischemic Stroke in Patients after Radiofrequency Catheter Ablation of Typical Atrial Flutter. Yonsei Medical Journal. 2018;59(2):236–42. DOI: 10.3349/ymj.2018.59.2.236
52. Huang SK, Miller JM. Catheter ablation of cardiac arrhythmias. 4th ed. Elsevier;2019. 834 p. ISBN 978-0-323-52992-1
53. Scheuermeyer FX, Pourvali R, Rowe BH, Grafstein E, Heslop C, MacPhee J et al. Emergency Department Patients With Atrial Fibrillation or Flutter and an Acute Underlying Medical Illness May Not Benefit From Attempts to Control Rate or Rhythm. Annals of Emergency Medicine. 2015;65(5):511-522.e2. DOI: 10.1016/j.annemergmed.2014.09.012
54. Huang JL, Tai C-T, Lin Y-J, Huang B-H, Lee K-T, Higa S et al. Substrate Mapping to Detect Abnormal Atrial Endocardium With Slow Conduction in Patients With Atypical Right Atrial Flutter. Journal of the American College of Cardiology. 2006;48(3):492–8. DOI: 10.1016/j.jacc.2006.03.045
55. Fromm C, Suau SJ, Cohen V, Likourezos A, Jellinek-Cohen S, Rose J et al. Diltiazem vs. Metoprolol in the Management of Atrial Fibrillation or Flutter with Rapid Ventricular Rate in the Emergency Department. The Journal of Emergency Medicine. 2015;49(2):175–82. DOI: 10.1016/j.jemermed.2015.01.014
56. Giehm-Reese M, Lukac P, Kristiansen SB, Jensen HK, Gerdes C, Kristensen J et al. Outcome after catheter ablation for left atrial flutter. Scandinavian Cardiovascular Journal. 2019;53(3):133–40. DOI: 10.1080/14017431.2019.1612086
57. Revishvili A.Sh., Shlyakhto E.V., Popov S.V., Pokushalov E.A., Shkolnikova M.A., Sulimov V.A. et al. Clinical recommendations for electrophysiological studies, catheter ablation and implantable antiarrhythmic devices. -M.: VNOA;2017. -702 p. [Russian] ISBN: 978-5-9500922-0-6 (http://webmed.irkutsk.ru/doc/pdf/vnoa.pdf)
58. Zhou G, Hu J, Guo X, Liu X, Yang J, Sun Q et al. Very long-term outcome of catheter ablation of post-incisional atrial tachycardia: Role of incisional and non-incisional scar. International Journal of Cardiology. 2016;205:72–80. DOI: 10.1016/j.ijcard.2015.12.004
59. Shah SR, Luu S-W, Calestino M, David J, Christopher B. Management of atrial fibrillation-flutter: uptodate guideline paper on the current evidence. Journal of Community Hospital Internal Medicine Perspectives. 2018;8(5):269–75. DOI: 10.1080/20009666.2018.1514932
60. Pérez FJ, Wood MA, Schubert CM. Effects of Gap Geometry on Conduction Through Discontinuous Radiofrequency Lesions. Circulation. 2006;113(14):1723–9. DOI: 10.1161/CIRCULATIONAHA.105.596593
61. Frommeyer G, Brachmann J, Ince H, Spitzer SG, Thomas D, Willems S et al. Digitalis therapy is associated with higher comorbidities and poorer prognosis in patients undergoing ablation of atrial arrhythmias: data from the German Ablation Registry. Clinical Research in Cardiology. 2019;108(10):1083–92. DOI: 10.1007/s00392-019-01442-w
62. January CT, Wann LS, Calkins H, Chen LY, Cigarroa JE, Cleveland JC et al. 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation. Heart Rhythm. 2019;16(8):e66–93. DOI: 10.1016/j.hrthm.2019.01.024
63. Page RL, Joglar JA, Caldwell MA, Calkins H, Conti JB, Deal BJ et al. 2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation. 2016;133(14):471–505. DOI: 10.1161/CIR.0000000000000310
64. Vadmann H, Nielsen PB, Hjortshøj SP, Riahi S, Rasmussen LH, Lip GYH et al. Atrial flutter and thromboembolic risk: a systematic review. Heart. 2015;101(18):1446–55. DOI: 10.1136/heartjnl-2015-307550
65. Sestito A, Molina E. Atrial fibrillation and the pharmacological treatment: the role of propafenone. European Review for Medical and Pharmacological Sciences. 2012;16(2):242–53. PMID: 22428477
66. Gula LJ, Redfearn DP, Jenkyn KB, Allen B, Skanes AC, Leong-Sit P et al. Elevated Incidence of Atrial Fibrillation and Stroke in Patients With Atrial Flutter—A Population-Based Study. Canadian Journal of Cardiology. 2018;34(6):774–83. DOI: 10.1016/j.cjca.2018.01.001
67. Vinson DR, Lugovskaya N, Warton EM, Rome AM, Stevenson MD, Reed ME et al. Ibutilide Effectiveness and Safety in the Cardioversion of Atrial Fibrillation and Flutter in the Community Emergency Department. Annals of Emergency Medicine. 2018;71(1):96-108.e2. DOI: 10.1016/j.annemergmed.2017.07.481
68. Al-Kawaz M, Omran SS, Parikh NS, Elkind MSV, Soliman EZ, Kamel H. Comparative Risks of Ischemic Stroke in Atrial Flutter versus Atrial Fibrillation. Journal of Stroke and Cerebrovascular Diseases. 2018;27(4):839–44. DOI: 10.1016/j.jstrokecerebrovasdis.2017.10.025
69. Wolbrette DL, Hussain S, Maraj I, Naccarelli GV. A Quarter of a Century Later: What is Dofetilide’s Clinical Role Today? Journal of Cardiovascular Pharmacology and Therapeutics. 2019;24(1):3–10. DOI: 10.1177/1074248418784288
70. Flaker G, Lopes RD, Al-Khatib SM, Hermosillo AG, Hohnloser SH, Tinga B et al. Efficacy and Safety of Apixaban in Patients After Cardioversion for Atrial Fibrillation. Journal of the American College of Cardiology. 2014;63(11):1082–7. DOI: 10.1016/j.jacc.2013.09.062
71. Abraham JM, Saliba WI, Vekstein C, Lawrence D, Bhargava M, Bassiouny M et al. Safety of Oral Dofetilide for Rhythm Control of Atrial Fibrillation and Atrial Flutter. Circulation: Arrhythmia and Electrophysiology. 2015;8(4):772–6. DOI: 10.1161/CIRCEP.114.002339
72. Monteiro JMC, San-Martin DL, Silva BCG, Souza IFB, Oliveira Filho J, Jesus P. Dabigatran and warfarin in nonvalvular atrial fibrillation or atrial flutter in outpatient clinic practice in Brazil. Arquivos de NeuroPsiquiatria. 2019;77(2):80–3. DOI: 10.1590/0004-282x20190005
73. Hamilton A, Clark D, Gray A, Cragg A, Grubb N. The epidemiology and management of recent-onset atrial fibrillation and flutter presenting to the Emergency Department. European Journal of Emergency Medicine. 2015;22(3):155–61. DOI: 10.1097/MEJ.0000000000000198
74. Lehrmann H, Weber R, Park C, Allgeier J, Schiebeling-Römer J, Arentz T et al. “Dormant transisthmus conduction” revealed by adenosine after cavotricuspid isthmus ablation. Heart Rhythm. 2012;9(12):1942–6. DOI: 10.1016/j.hrthm.2012.08.020
75. Maykov E.B., Yuricheva Yu.A., Mironov N.Yu., Sokolov S.F., Golitsyn S.P., Rozenshtraukh L.V. et al. Refralon (niferidil) is a new class III antiarrhythmic agent for pharmacological cardioversion for persistent atrial fibrillation and atrial flutter. Therapeutic Archive. 2015;87(1):38–48. [Russian] DOI: 10.17116/terarkh201587138-48
76. Brugada J, Katritsis DG, Arbelo E, Arribas F, Bax JJ, Blomström-Lundqvist C et al. 2019 ESC Guidelines for the management of patients with supraventricular tachycardiaThe Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC). European Heart Journal. 2019;ehz467. [Epub ahead of print]. DOI: 10.1093/eurheartj/ehz467
77. Amin A, Houmsse A, Ishola A, Tyler J, Houmsse M. The current approach of atrial fibrillation management. Avicenna Journal of Medicine. 2016;6(1):8–16. DOI: 10.4103/2231-0770.173580
78. Jin M-N, Song C, Kim T-H, Uhm J-S, Pak H-N, Lee M-H et al. CHA2DS2-VASc Score in the Prediction of Ischemic Stroke in Patients after Radiofrequency Catheter Ablation of Typical Atrial Flutter. Yonsei Medical Journal. 2018;59(2):236–42. DOI: 10.3349/ymj.2018.59.2.236
79. Naccarelli G, Kowey P. The Role of Dronedarone in the Treatment of Atrial Fibrillation/Flutter in the Aftermath of PALLAS. Current Cardiology Reviews. 2014;10(4):303–8. DOI: 10.2174/1573403X10666140513110247
80. Scheuermeyer FX, Pourvali R, Rowe BH, Grafstein E, Heslop C, MacPhee J et al. Emergency Department Patients With Atrial Fibrillation or Flutter and an Acute Underlying Medical Illness May Not Benefit From Attempts to Control Rate or Rhythm. Annals of Emergency Medicine. 2015;65(5):511-522.e2. DOI: 10.1016/j.annemergmed.2014.09.012
81. Sokolov S.F., Bomonina E.V. Comparative efficacy and safety of allapinine, ethacyzin and amiodarone: choice of optimal antiarrhythmic therapy for rhythm control in case of paroxysmal atrial fibrillation. Cardiology: news, opinions, training. 2015;3(6):65–75. [Russian]
82. Fromm C, Suau SJ, Cohen V, Likourezos A, Jellinek-Cohen S, Rose J et al. Diltiazem vs. Metoprolol in the Management of Atrial Fibrillation or Flutter with Rapid Ventricular Rate in the Emergency Department. The Journal of Emergency Medicine. 2015;49(2):175–82. DOI: 10.1016/j.jemermed.2015.01.014
83. Kirkland S, Stiell I, AlShawabkeh T, Campbell S, Dickinson G, Rowe BH. The Efficacy of Pad Placement for Electrical Cardioversion of Atrial Fibrillation/Flutter: A Systematic Review. Academic Emergency Medicine. 2014;21(7):717–26. DOI: 10.1111/acem.12407
84. Revishvili A.Sh., Shlyakhto E.V., Popov S.V., Pokushalov E.A., Shkolnikova M.A., Sulimov V.A. et al. Clinical recommendations for electrophysiological studies, catheter ablation and implantable antiarrhythmic devices. -M.: VNOA;2017. -702 p. [Russian] ISBN: 978-5-9500922-0-6 (http://webmed.irkutsk.ru/doc/pdf/vnoa.pdf)
85. Grönberg T, Nuotio I, Nikkinen M, Ylitalo A, Vasankari T, Hartikainen JEK et al. Arrhythmic complications after electrical cardioversion of acute atrial fibrillation: The FinCV study. EP Europace. 2013;15(10):1432–5. DOI: 10.1093/europace/eut106
86. Shah SR, Luu S-W, Calestino M, David J, Christopher B. Management of atrial fibrillation-flutter: uptodate guideline paper on the current evidence. Journal of Community Hospital Internal Medicine Perspectives. 2018;8(5):269–75. DOI: 10.1080/20009666.2018.1514932
87. Сулимов В. А., Дубровский И. А., Канорский С. Г. и др. Чреспищеводная электрическая стимуляция сердца, 2-е издание. – М.:ГЭОТАР-Медиа, 2015. 216с. ISBN 978-5-9704-3209-9
88. Frommeyer G, Brachmann J, Ince H, Spitzer SG, Thomas D, Willems S et al. Digitalis therapy is associated with higher comorbidities and poorer prognosis in patients undergoing ablation of atrial arrhythmias: data from the German Ablation Registry. Clinical Research in Cardiology. 2019;108(10):1083–92. DOI: 10.1007/s00392-019-01442-w
89. Olesin A.I., Smolin Z.Yu., Konovalova O.A., Shabrov A.V. Evaluation of the effectiveness of transesophageal electrocardiostimulation for the treatment of the first detected atrial flutter type I in patients with coronary heart disease. Therapeutic Archive. 2009;81(9):37– 41. [Russian]
90. Page RL, Joglar JA, Caldwell MA, Calkins H, Conti JB, Deal BJ et al. 2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation. 2016;133(14):471–505. DOI: 10.1161/CIR.0000000000000310
91. Spector P, Reynolds MR, Calkins H, Sondhi M, Xu Y, Martin A et al. Meta-Analysis of Ablation of Atrial Flutter and Supraventricular Tachycardia. The American Journal of Cardiology. 2009;104(5):671– 7. DOI: 10.1016/j.amjcard.2009.04.040
92. Sestito A, Molina E. Atrial fibrillation and the pharmacological treatment: the role of propafenone. European Review for Medical and Pharmacological Sciences. 2012;16(2):242–53. PMID: 22428477
93. Brembilla-Perrot B, Sellal JM, Olivier A, Manenti V, Villemin T, Beurrier D et al. Risk and Outcome after Ablation of Isthmus-Dependent Atrial Flutter in Elderly Patients. PLOS ONE. 2015;10(5):e0127672. DOI: 10.1371/journal.pone.0127672
94. Vinson DR, Lugovskaya N, Warton EM, Rome AM, Stevenson MD, Reed ME et al. Ibutilide Effectiveness and Safety in the Cardioversion of Atrial Fibrillation and Flutter in the Community Emergency Department. Annals of Emergency Medicine. 2018;71(1):96-108.e2. DOI: 10.1016/j.annemergmed.2017.07.481
95. Zeng Q, Li X, Xu G. Evaluation of myocardial injury induced by different ablation approaches (radiofrequency ablation versus cryoablation) in atrial flutter patients: a meta-analysis. Bioscience Reports. 2019;39(5):BSR20182251. DOI: 10.1042/BSR20182251
96. Wolbrette DL, Hussain S, Maraj I, Naccarelli GV. A Quarter of a Century Later: What is Dofetilide’s Clinical Role Today? Journal of Cardiovascular Pharmacology and Therapeutics. 2019;24(1):3–10. DOI: 10.1177/1074248418784288
97. Pérez FJ, Schubert CM, Parvez B, Pathak V, Ellenbogen KA, Wood MA. Long-Term Outcomes After Catheter Ablation of CavoTricuspid Isthmus Dependent Atrial Flutter: A Meta-Analysis. Circulation: Arrhythmia and Electrophysiology. 2009;2(4):393–401. DOI: 10.1161/CIRCEP.109.871665
98. Abraham JM, Saliba WI, Vekstein C, Lawrence D, Bhargava M, Bassiouny M et al. Safety of Oral Dofetilide for Rhythm Control of Atrial Fibrillation and Atrial Flutter. Circulation: Arrhythmia and Electrophysiology. 2015;8(4):772–6. DOI: 10.1161/CIRCEP.114.002339
99. Kumar S, Morton JB, Lee G, Halloran K, Kistler PM, Kalman JM. High Incidence of Low Catheter-Tissue Contact Force at the Cavotricuspid Isthmus During Catheter Ablation of Atrial Flutter: Implications for Achieving Isthmus Block. Journal of Cardiovascular Electrophysiology. 2015;26(8):826–31. DOI: 10.1111/jce.12707
100. Hamilton A, Clark D, Gray A, Cragg A, Grubb N. The epidemiology and management of recent-onset atrial fibrillation and flutter presenting to the Emergency Department. European Journal of Emergency Medicine. 2015;22(3):155–61. DOI: 10.1097/MEJ.0000000000000198
101. Venier S, Andrade JG, Khairy P, Mondésert B, Dyrda K, Rivard L et al. Contact-force-guided vs. contact-force-blinded catheter ablation of typical atrial flutter: a prospective study. Europace. 2016;19(6):1043–8. DOI: 10.1093/europace/euw137
102. Maykov E.B., Yuricheva Yu.A., Mironov N.Yu., Sokolov S.F., Golitsyn S.P., Rozenshtraukh L.V. et al. Refralon (niferidil) is a new class III antiarrhythmic agent for pharmacological cardioversion for persistent atrial fibrillation and atrial flutter. Therapeutic Archive. 2015;87(1):38–48. [Russian] DOI: 10.17116/terarkh201587138-48
103. Yang Y, Varma N, Badhwar N, Tanel RE, Sundara S, Lee RJ et al. Prospective Observations in the Clinical and Electrophysiological Characteristics of Intra-Isthmus Reentry. Journal of Cardiovascular Electrophysiology. 2010;21(10):1099–106. DOI: 10.1111/j.1540-8167.2010.01778.x
104. Amin A, Houmsse A, Ishola A, Tyler J, Houmsse M. The current approach of atrial fibrillation management. Avicenna Journal of Medicine. 2016;6(1):8–16. DOI: 10.4103/2231-0770.173580
105. Coffey JO, d’Avila A, Dukkipati S, Danik SB, Gangireddy SR, Koruth JS et al. Catheter ablation of scar-related atypical atrial flutter. EP Europace. 2013;15(3):414–9. DOI: 10.1093/europace/eus312
106. Naccarelli G, Kowey P. The Role of Dronedarone in the Treatment of Atrial Fibrillation/Flutter in the Aftermath of PALLAS. Current Cardiology Reviews. 2014;10(4):303–8. DOI: 10.2174/1573403X10666140513110247
107. Skjøth F, Vadmann H, Hjortshøj SP, Riahi S, Lip GYH, Larsen TB. Disease progression after ablation for atrial flutter compared with atrial fibrillation: A nationwide cohort study. International Journal of Clinical Practice. 2018;72(11):e13258. DOI: 10.1111/ijcp.13258
108. Sokolov S.F., Bomonina E.V. Comparative efficacy and safety of allapinine, ethacyzin and amiodarone: choice of optimal antiarrhythmic therapy for rhythm control in case of paroxysmal atrial fibrillation. Cardiology: news, opinions, training. 2015;3(6):65–75. [Russian]
109. Lin Y, Chen T, Chi C, Lin M, Tung T, Liu C et al. Different Implications of Heart Failure, Ischemic Stroke, and Mortality Between Nonvalvular Atrial Fibrillation and Atrial Flutter—a View From a National Cohort Study. Journal of the American Heart Association. 2017;6(7):e006406. DOI: 10.1161/JAHA.117.006406
110. Kirkland S, Stiell I, AlShawabkeh T, Campbell S, Dickinson G, Rowe BH. The Efficacy of Pad Placement for Electrical Cardioversion of Atrial Fibrillation/Flutter: A Systematic Review. Academic Emergency Medicine. 2014;21(7):717–26. DOI: 10.1111/acem.12407
111. Bogossian H, Frommeyer G, Brachmann J, Lewalter T, Hoffmann E, Kuck KH et al. Catheter ablation of atrial fibrillation and atrial flutter in patients with diabetes mellitus: Who benefits and who does not? Data from the German ablation registry. International Journal of Cardiology. 2016;214:25–30. DOI: 10.1016/j.ijcard.2016.03.069
112. Grönberg T, Nuotio I, Nikkinen M, Ylitalo A, Vasankari T, Hartikainen JEK et al. Arrhythmic complications after electrical cardioversion of acute atrial fibrillation: The FinCV study. EP Europace. 2013;15(10):1432–5. DOI: 10.1093/europace/eut106
113. Steinbeck G, Sinner MF, Lutz M, Müller-Nurasyid M, Kääb S, Reinecke H. Incidence of complications related to catheter ablation of atrial fibrillation and atrial flutter: a nationwide in-hospital analysis of administrative data for Germany in 2014. European Heart Journal. 2018;39(45):4020–9. DOI: 10.1093/eurheartj/ehy452
114. Сулимов В. А., Дубровский И. А., Канорский С. Г. и др. Чреспищеводная электрическая стимуляция сердца, 2-е издание. – М.:ГЭОТАР-Медиа, 2015. 216с. ISBN 978-5-9704-3209-9
115. Warchoł I, Bińkowski BJ, Kucejko T, Sobiczewska J, Lubiński A. A Retrospective Study of Atrial Fibrillation Following Cavotricuspid Isthmus Ablation for Atrial Flutter. Medical Science Monitor. 2019;25:3316–20. DOI: 10.12659/MSM.912918
116. Olesin A.I., Smolin Z.Yu., Konovalova O.A., Shabrov A.V. Evaluation of the effectiveness of transesophageal electrocardiostimulation for the treatment of the first detected atrial flutter type I in patients with coronary heart disease. Therapeutic Archive. 2009;81(9):37– 41. [Russian]
117. De Bortoli A, Shi L-B, Ohm O-J, Hoff PI, Schuster P, Solheim E et al. Incidence and clinical predictors of subsequent atrial fibrillation requiring additional ablation after cavotricuspid isthmus ablation for typical atrial flutter. Scandinavian Cardiovascular Journal. 2017;51(3):123–8. DOI: 10.1080/14017431.2017.1304570
118. Spector P, Reynolds MR, Calkins H, Sondhi M, Xu Y, Martin A et al. Meta-Analysis of Ablation of Atrial Flutter and Supraventricular Tachycardia. The American Journal of Cardiology. 2009;104(5):671– 7. DOI: 10.1016/j.amjcard.2009.04.040
119. Chen K, Bai R, Deng W, Gao C, Zhang J, Wang X et al. HATCH score in the prediction of new-onset atrial fibrillation after catheter ablation of typical atrial flutter. Heart Rhythm. 2015;12(7):1483–9. DOI: 10.1016/j.hrthm.2015.04.008
120. Brembilla-Perrot B, Sellal JM, Olivier A, Manenti V, Villemin T, Beurrier D et al. Risk and Outcome after Ablation of Isthmus-Dependent Atrial Flutter in Elderly Patients. PLOS ONE. 2015;10(5):e0127672. DOI: 10.1371/journal.pone.0127672
121. Teh AW, Medi C, Lee G, Rosso R, Sparks PB, Morton JB et al. Longterm Outcome Following Ablation of Atrial Flutter Occurring Late after Atrial Septal Defect Repair: LATE AF AFTER ASD REPAIR SURGERY. Pacing and Clinical Electrophysiology. 2011;34(4):431–5. DOI: 10.1111/j.1540-8159.2010.03005.x
122. Zeng Q, Li X, Xu G. Evaluation of myocardial injury induced by different ablation approaches (radiofrequency ablation versus cryoablation) in atrial flutter patients: a meta-analysis. Bioscience Reports. 2019;39(5):BSR20182251. DOI: 10.1042/BSR20182251
123. Expósito V, Rodríguez-Entem F, González-Enríquez S, Veiga G, Olavarri I, Olalla JJ. Stroke and Systemic Embolism After Successful Ablation of Typical Atrial Flutter. Clinical Cardiology. 2016;39(6):347–51. DOI: 10.1002/clc.22538
124. Pérez FJ, Schubert CM, Parvez B, Pathak V, Ellenbogen KA, Wood MA. Long-Term Outcomes After Catheter Ablation of CavoTricuspid Isthmus Dependent Atrial Flutter: A Meta-Analysis. Circulation: Arrhythmia and Electrophysiology. 2009;2(4):393–401. DOI: 10.1161/CIRCEP.109.871665
125. Steinberg JS, Romanov A, Musat D, Preminger M, Bayramova S, Artyomenko S et al. Prophylactic pulmonary vein isolation during isthmus ablation for atrial flutter: The PReVENT AF Study I. Heart Rhythm. 2014;11(9):1567–72. DOI: 10.1016/j.hrthm.2014.05.011
126. Kumar S, Morton JB, Lee G, Halloran K, Kistler PM, Kalman JM. High Incidence of Low Catheter-Tissue Contact Force at the Cavotricuspid Isthmus During Catheter Ablation of Atrial Flutter: Implications for Achieving Isthmus Block. Journal of Cardiovascular Electrophysiology. 2015;26(8):826–31. DOI: 10.1111/jce.12707
127. Stiles MK, Wong CX, John B, Kuklik P, Brooks AG, Lau DH et al. Characterization of Atrial Remodeling Studied Remote from Episodes of Typical Atrial Flutter. The American Journal of Cardiology. 2010;106(4):528–34. DOI: 10.1016/j.amjcard.2010.03.069
128. Venier S, Andrade JG, Khairy P, Mondésert B, Dyrda K, Rivard L et al. Contact-force-guided vs. contact-force-blinded catheter ablation of typical atrial flutter: a prospective study. Europace. 2016;19(6):1043–8. DOI: 10.1093/europace/euw137
129. Medi C, Teh AW, Roberts-Thomson K, Morton JB, Kistler PM, Kalman JM. Right Atrial Remodeling is More Advanced in Patients with Atrial Flutter Than with Atrial Fibrillation. Journal of Cardiovascular Electrophysiology. 2012;23(10):1067–72. DOI: 10.1111/j.1540-8167.2012.02364.x
130. Yang Y, Varma N, Badhwar N, Tanel RE, Sundara S, Lee RJ et al. Prospective Observations in the Clinical and Electrophysiological Characteristics of Intra-Isthmus Reentry. Journal of Cardiovascular Electrophysiology. 2010;21(10):1099–106. DOI: 10.1111/j.1540-8167.2010.01778.x
131. Coffey JO, d’Avila A, Dukkipati S, Danik SB, Gangireddy SR, Koruth JS et al. Catheter ablation of scar-related atypical atrial flutter. EP Europace. 2013;15(3):414–9. DOI: 10.1093/europace/eus312
132. Skjøth F, Vadmann H, Hjortshøj SP, Riahi S, Lip GYH, Larsen TB. Disease progression after ablation for atrial flutter compared with atrial fibrillation: A nationwide cohort study. International Journal of Clinical Practice. 2018;72(11):e13258. DOI: 10.1111/ijcp.13258
133. Lin Y, Chen T, Chi C, Lin M, Tung T, Liu C et al. Different Implications of Heart Failure, Ischemic Stroke, and Mortality Between Nonvalvular Atrial Fibrillation and Atrial Flutter—a View From a National Cohort Study. Journal of the American Heart Association. 2017;6(7):e006406. DOI: 10.1161/JAHA.117.006406
134. Bogossian H, Frommeyer G, Brachmann J, Lewalter T, Hoffmann E, Kuck KH et al. Catheter ablation of atrial fibrillation and atrial flutter in patients with diabetes mellitus: Who benefits and who does not? Data from the German ablation registry. International Journal of Cardiology. 2016;214:25–30. DOI: 10.1016/j.ijcard.2016.03.069
135. Steinbeck G, Sinner MF, Lutz M, Müller-Nurasyid M, Kääb S, Reinecke H. Incidence of complications related to catheter ablation of atrial fibrillation and atrial flutter: a nationwide in-hospital analysis of administrative data for Germany in 2014. European Heart Journal. 2018;39(45):4020–9. DOI: 10.1093/eurheartj/ehy452
136. Warchoł I, Bińkowski BJ, Kucejko T, Sobiczewska J, Lubiński A. A Retrospective Study of Atrial Fibrillation Following Cavotricuspid Isthmus Ablation for Atrial Flutter. Medical Science Monitor. 2019;25:3316–20. DOI: 10.12659/MSM.912918
137. De Bortoli A, Shi L-B, Ohm O-J, Hoff PI, Schuster P, Solheim E et al. Incidence and clinical predictors of subsequent atrial fibrillation requiring additional ablation after cavotricuspid isthmus ablation for typical atrial flutter. Scandinavian Cardiovascular Journal. 2017;51(3):123–8. DOI: 10.1080/14017431.2017.1304570
138. Chen K, Bai R, Deng W, Gao C, Zhang J, Wang X et al. HATCH score in the prediction of new-onset atrial fibrillation after catheter ablation of typical atrial flutter. Heart Rhythm. 2015;12(7):1483–9. DOI: 10.1016/j.hrthm.2015.04.008
139. Teh AW, Medi C, Lee G, Rosso R, Sparks PB, Morton JB et al. Longterm Outcome Following Ablation of Atrial Flutter Occurring Late after Atrial Septal Defect Repair: LATE AF AFTER ASD REPAIR SURGERY. Pacing and Clinical Electrophysiology. 2011;34(4):431–5. DOI: 10.1111/j.1540-8159.2010.03005.x
140. Expósito V, Rodríguez-Entem F, González-Enríquez S, Veiga G, Olavarri I, Olalla JJ. Stroke and Systemic Embolism After Successful Ablation of Typical Atrial Flutter. Clinical Cardiology. 2016;39(6):347–51. DOI: 10.1002/clc.22538
141. Steinberg JS, Romanov A, Musat D, Preminger M, Bayramova S, Artyomenko S et al. Prophylactic pulmonary vein isolation during isthmus ablation for atrial flutter: The PReVENT AF Study I. Heart Rhythm. 2014;11(9):1567–72. DOI: 10.1016/j.hrthm.2014.05.011
142. Stiles MK, Wong CX, John B, Kuklik P, Brooks AG, Lau DH et al. Characterization of Atrial Remodeling Studied Remote from Episodes of Typical Atrial Flutter. The American Journal of Cardiology. 2010;106(4):528–34. DOI: 10.1016/j.amjcard.2010.03.069
143. Medi C, Teh AW, Roberts-Thomson K, Morton JB, Kistler PM, Kalman JM. Right Atrial Remodeling is More Advanced in Patients with Atrial Flutter Than with Atrial Fibrillation. Journal of Cardiovascular Electrophysiology. 2012;23(10):1067–72. DOI: 10.1111/j.1540-8167.2012.02364.x
Review
For citations:
Potapova K.V., Nosov V.P., Koroleva L.Y., Amineva N.V. Atrial Flutter: up‐to‐date Problem Evaluation with Clinical Positions. Kardiologiia. 2020;60(1):70-80. (In Russ.) https://doi.org/10.18087/cardio.2020.1.n693
Views:
2883
Email this article 
Post a Comment 
